140 related articles for article (PubMed ID: 35107742)
1. MMP-9 secreted by M2-type macrophages promotes Wilms' tumour metastasis through the PI3K/AKT pathway.
Tian K; Du G; Wang X; Wu X; Li L; Liu W; Wu R
Mol Biol Rep; 2022 May; 49(5):3469-3480. PubMed ID: 35107742
[TBL] [Abstract][Full Text] [Related]
2. Relationship of tumour-associated macrophages with poor prognosis in Wilms' tumour.
Tian K; Wang X; Wu Y; Wu X; Du G; Liu W; Wu R
J Pediatr Urol; 2020 Jun; 16(3):376.e1-376.e8. PubMed ID: 32299765
[TBL] [Abstract][Full Text] [Related]
3. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
Liu GL; Yang HJ; Liu B; Liu T
J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
[TBL] [Abstract][Full Text] [Related]
4. MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway.
Liu L; Ye Y; Zhu X
Biomed Pharmacother; 2019 Sep; 117():109096. PubMed ID: 31202170
[TBL] [Abstract][Full Text] [Related]
5. PDGF-BB/PDGFRβ promotes epithelial-mesenchymal transition by affecting PI3K/AKT/mTOR-driven aerobic glycolysis in Wilms' tumor G401 cells.
Guo JQ; Wang CD; Tang HY; Sang BT; Liu X; Yi FP; Wu XM
Cell Biol Int; 2022 Jun; 46(6):907-921. PubMed ID: 35165984
[TBL] [Abstract][Full Text] [Related]
6. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
7. M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.
Sun D; Luo T; Dong P; Zhang N; Chen J; Zhang S; Dong L; Janssen HLA; Zhang S
J Cell Biochem; 2020 Apr; 121(4):2828-2838. PubMed ID: 31692069
[TBL] [Abstract][Full Text] [Related]
8. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.
Zhou Z; Peng Y; Wu X; Meng S; Yu W; Zhao J; Zhang H; Wang J; Li W
Cell Oncol (Dordr); 2019 Feb; 42(1):81-92. PubMed ID: 30276551
[TBL] [Abstract][Full Text] [Related]
9. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages.
Wang L; Li S; Luo H; Lu Q; Yu S
J Exp Clin Cancer Res; 2022 Oct; 41(1):303. PubMed ID: 36242053
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
11. PDGF-BB/PDGFRβ induces tumour angiogenesis via enhancing PKM2 mediated by the PI3K/AKT pathway in Wilms' tumour.
Sang BT; Wang CD; Liu X; Guo JQ; Lai JY; Wu XM
Med Oncol; 2023 Jul; 40(8):240. PubMed ID: 37442847
[TBL] [Abstract][Full Text] [Related]
12. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.
Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL
Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129
[TBL] [Abstract][Full Text] [Related]
13. Over-Expression of miR-21 and Lower PTEN Levels in Wilms' Tumor with Aggressive Behavior.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
Tohoku J Exp Med; 2017 May; 242(1):43-52. PubMed ID: 28529243
[TBL] [Abstract][Full Text] [Related]
14. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin B modulates M2 macrophage differentiation and attenuates osteosarcoma progression via PI3K/AKT pathway.
Wu H; Ma T; He M; Xie W; Wang X; Lu L; Wang H; Cui Y
Phytother Res; 2024 May; 38(5):2215-2233. PubMed ID: 38411031
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
17. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
Zeng J; Yang X; Yang L; Li W; Zheng Y
Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
[TBL] [Abstract][Full Text] [Related]
18. Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors.
Polosukhina D; Love HD; Correa H; Su Z; Dahlman KB; Pao W; Moses HL; Arteaga CL; Lovvorn HN; Zent R; Clark PE
Mol Oncol; 2017 Apr; 11(4):405-421. PubMed ID: 28188683
[TBL] [Abstract][Full Text] [Related]
19. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
